myo-inositol trispyrophosphate Powder Bulk

Formula

C6H12O21P6

Synonyms

Myo inositol Trispyrophosphate powder, Myo-inositol Trispyrophosphate powder, ITPP Powder

Appearance

White fine Powder

Grade

Food grade, medical grade

Solubility

insoluble in water

Ash content

<0.5%

Purity

98% min

CAS Number

23103-35-7, 802590-64-3

stannic oxide Ceramic Powder for sale

Description of Myo inositol Trispyrophosphate ITPP powder

Myo-inositol trispyrophosphate (ITPP) is a lab-made molecule derived from myo-inositol, a natural sugar. It helps hemoglobin in blood release oxygen more easily, improving oxygen delivery to tissues. This makes it potentially useful for treating conditions like cancer and heart disease that involve low oxygen levels.

Princeton Powder is a wholesale supplier of pure ITPP powder in USA. Our extensive manufacturing expertise ensures reliable, tailored solutions to effectively support your projects. Myo-inositol trispyrophosphate bulk powder is for sale at a competitive price.

Specification

Attribute Details
Model Number PP-Myo-inositol Trispyrophosphate
Product Name Myo-inositol Trispyrophosphate
Appearance White powder
Other Name ITPP
Assay HPLC 98%
Form Powder
Application Hormone Balance & Healthy Ovarian Support for Women
Packaging Foil Bag/Drum
Shelf Life 2 years
Certificate ISO9001, COA, Kosher
Storage Dry Place

Applications

  • Therapeutic Uses: ITPP is being studied for its potential to treat conditions characterized by hypoxia (low oxygen levels in tissues), such as cancer, cardiovascular diseases, and chronic obstructive pulmonary disease (COPD).
  • Performance Enhancement: There has been interest in ITPP for its potential to enhance athletic performance by improving oxygen delivery to muscles. However, its use in sports is controversial and raises ethical and safety concerns.

ITPP Powder Reference

FAQs

Have any questions?

Leave your questions, we will answer as soon as possible.

Myo-inositol trispyrophosphate (ITPP) increases tissue O2 release acting on Hb. ITPP reduces cancer progression through alleviation of hypoxia. ITPP increases myocardial pO2 in cardiovascular diseases. It prevents cardiac remodeling and improves exercise capacity in heart failure.